The clinical manifestations and management of COVID-19-related liver injury
Authors:
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 119 (6) , 1016-1018
Abstract
No abstract availableFunding Information
- Ministry of Science and Technology, Taiwan (MOST 108-2628-B-002-003)
- National Taiwan University Hospital (VN109-06, NTUH-109-T20, NTUH-109-S4711)
- Liver Disease Prevention & Treatment Research Foundation, Taiwan
This publication has 13 references indexed in Scilit:
- Liver injury in COVID-19: management and challengesThe Lancet Gastroenterology & Hepatology, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Pathological findings of COVID-19 associated with acute respiratory distress syndromeThe Lancet Respiratory Medicine, 2020
- Coronaviruses and Immunosuppressed Patients: The Facts During the Third EpidemicLiver Transplantation, 2020
- Liver injury during highly pathogenic human coronavirus infectionsLiver International, 2020
- Detection of SARS-CoV-2 in Different Types of Clinical SpecimensJAMA, 2020
- First case of Coronavirus Disease 2019 (COVID-19) pneumonia in TaiwanJournal of the Formosan Medical Association, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Overexpression of 7a, a Protein Specifically Encoded by the Severe Acute Respiratory Syndrome Coronavirus, Induces Apoptosis via a Caspase-Dependent PathwayJournal of Virology, 2004
- Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathwaysThe Journal of Pathology, 2004